Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-21-034421
Filing Date
2021-10-12
Accepted
2021-10-12 19:47:31
Documents
1
Period of Report
2021-10-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 3912
  Complete submission text file 0001140361-21-034421.txt   5305
Mailing Address C/O REXAHN PHARMACEUTICALS, INC. 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address
Sullivan Lara (Reporting) CIK: 0001769457 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40881 | Film No.: 211319816

Mailing Address 800 BOYLSTON STREET SUITE 1555 BOSTON MA 02199
Business Address 800 BOYLSTON STREET SUITE 1555 BOSTON MA 02199 (617) 351-2575
Pyxis Oncology, Inc. (Issuer) CIK: 0001782223 (see all company filings)

EIN.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations